Rodman & Renshaw Capital Group announced it has hired Dr. Simos Simeonidis as a director and senior biotechnology analyst who will cover the small and mid-cap biotechnology and specialty pharmaceuticals sector.
Dr. Simos Simeonidis joins Rodman’s New York office from First Albany Capital where he was a vice president and senior biotechnology analyst covering the small and mid-cap biotechnology and specialty pharmaceuticals sector.
Prior to this, Dr. Simeonidis was a member of the biotechnology equity research group at Morgan Stanley. Before that, he was an associate director in the business development/licensing and strategic planning groups at Novartis.-Business Wire
